IGUB19002 / NIAGARA / Chunkit Fung
Research Question:
What is the Efficacy and Safety of Durvalumab in Combination with Gemcitabine+Cisplatin
for Neoadjuvant Treatment and Durvalumab Alone for Adjuvant Treatment in Patients
with Muscle-Invasive Bladder Cancer?
Basic Study Information
Purpose:
A Global Study to Determine the Efficacy and Safety of Durvalumab in Combination with
Gemcitabine+Cisplatin for Neoadjuvant Treatment and Durvalumab Alone for Adjuvant
Treatment in Patients with Muscle-Invasive Bladder Cancer
Location: University of Rochester Medical Center
Study Reference #: IGUB19002
Lead Researcher (Principal Investigator)
Lead Researcher:
Chunkit Fung
Study Contact Information
Study Coordinator: Tina Bowdish
Phone: +1 585-275-9475
Email: tina_bowdish@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search